[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Country: Trend Forecast and Growth Opportunity

December 2021 | 141 pages | ID: E3ACDC9E5885EN
GMD Research

US$ 2,363.00 US$ 2,780.00 -15 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Bioelectric medicines, also known as electroceuticals, are medical devices that are used to restore health in patients. Bioelectric medicines function through neurostimulation and modulation of the nervous systems through electrical impulses. Europe bioelectric medicine market was valued at $5,859.6 million in 2020 and will grow by 6.4% annually over 2020-2030 owing to the growing geriatric population and rising acceptance of bioelectric medicines.

Highlighted with 70 tables and 43 figures, this 141-page report “Europe Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe bioelectric medicine market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2030 with 2019 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:
  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe bioelectric medicine market in every aspect of the classification from perspectives of Product Type, End User, and Country.

Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
  • Implantable Bioelectric Medicine
    • Cardiac Pacemaker
    • Implantable Cardioverter Defibrillators (ICD)
        • Spinal Cord Stimulators (split into Chronic Pain, Failed Back Syndrome (FBSS), Ischemia by application)
    • Cochlear Implants
        • Deep Brain Stimulators (split into Parkinson’s Disease, Tremor, Depression, Other Deep Brain Stimulation Applications by application)
    • Vagus Nerve Stimulators
        • Sacral Nerve Stimulators (split into Urinary Incontinence and Fecal Incontinence by application)
    • Retinal Implants
    • Other Implantable Bioelectric Medicines
  • Non-invasive Bioelectric Medicine
    • Transcutaneous Electrical Nerve Stimulators
    • Transcranial Magnetic Stimulation (TMS)
    • Pulsed Electromagnetic Field Therapy
    • Other Non-invasive Bioelectric Medicines
Based on End User, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
  • Hospitals and Clinics
  • Research Institutes
  • Individual Users
Geographically, the following national/local markets are fully investigated:
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
      • Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of the regional market by country and split of key national markets by Product Type and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in Europe bioelectric medicine market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

Abbott Laboratories

BIOTRONIK SE & Co. KG

Boston Scientific Corporation

Cochlear Limited

electroCore, Inc.

Inspire Medical Systems, Inc.

LivaNova PLC

Medtronic PLC

NeuroMetrix, Inc

Nevro Corp.

Nuvectra Corporation

OMRON CORPORATION

Pixium Vision

Second Sight Medical Products Inc

SetPoint Medical

Sonova Holding AG

St. Jude Medical, Inc.

Stimwave LLC

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF EUROPE MARKET BY PRODUCT TYPE

3.1 Market Overview by Product Type
3.2 Implantable Bioelectric Medicine
  3.2.1 Cardiac Pacemaker
  3.2.2 Implantable Cardioverter Defibrillators (ICD)
  3.2.3 Spinal Cord Stimulators
  3.2.4 Cochlear Implants
  3.2.5 Deep Brain Stimulators
  3.2.6 Vagus Nerve Stimulators
  3.2.7 Sacral Nerve Stimulators
  3.2.8 Retinal Implants
  3.2.9 Other Implantable Bioelectric Medicines
3.3 Non-invasive Bioelectric Medicine
  3.3.1 Transcutaneous Electrical Nerve Stimulators
  3.3.2 Transcranial Magnetic Stimulation (TMS)
  3.3.3 Pulsed Electromagnetic Field Therapy
  3.3.4 Other Non-invasive Bioelectric Medicines

4 SEGMENTATION OF EUROPE MARKET BY END USER

4.1 Market Overview by End User
4.2 Hospitals and Clinics
4.3 Research Institutes
4.4 Individual Users

5 EUROPEAN MARKET 2020-2030 BY COUNTRY

5.1 Overview of European Market
5.2 Germany
5.3 UK
5.4 France
5.5 Spain
5.6 Italy
5.7 Russia
5.8 Rest of European Market

6 COMPETITIVE LANDSCAPE

6.1 Overview of Key Vendors
6.2 New Product Launch, Partnership, Investment, and M&A
6.3 Company Profiles
Abbott Laboratories
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Cochlear Limited
electroCore, Inc.
Inspire Medical Systems, Inc.
LivaNova PLC
Medtronic PLC
NeuroMetrix, Inc
Nevro Corp.
Nuvectra Corporation
OMRON CORPORATION
Pixium Vision
Second Sight Medical Products Inc
SetPoint Medical
Sonova Holding AG
St. Jude Medical, Inc.
Stimwave LLC

7 INVESTING IN EUROPE MARKET: RISK ASSESSMENT AND MANAGEMENT

7.1 Risk Evaluation of Europe Market
7.2 Critical Success Factors (CSFs)
Related Reports and Products

LIST OF TABLES

Table 1. Snapshot of Europe Bioelectric Medicine Market in Balanced Perspective, 2020-2030
Table 2. Growth Rate of World GDP, 2020-2022
Table 3. Projection of Europe Disease Incidences Treated by Bioelectric Medicine, 2019-2030, million
Table 4. World Health Spending by Region, $ bn, 2013-2020
Table 5. Selected Examples of Product Recalls
Table 6. Main Product Trends and Market Opportunities in Europe Bioelectric Medicine Market
Table 7. Europe Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 8. Europe Implantable Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 9. Europe Bioelectric Medicine Market: Spinal Cord Stimulators by Application, 2019-2030, $ mn
Table 10. Europe Bioelectric Medicine Market: Deep Brain Stimulators by Application, 2019-2030, $ mn
Table 11. Europe Bioelectric Medicine Market: Sacral Nerve Stimulators by Application, 2019-2030, $ mn
Table 12. Europe Non-invasive Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 13. Europe Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 14. Europe Bioelectric Medicine Market by Country, 2019-2030, $ mn
Table 15. Germany Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 16. Germany Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 17. UK Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 18. UK Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 19. France Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 20. France Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 21. Spain Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 22. Spain Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 23. Italy Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 24. Italy Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 25. Russia Bioelectric Medicine Market by Product Type, 2019-2030, $ mn
Table 26. Russia Bioelectric Medicine Market by End User, 2019-2030, $ mn
Table 27. Bioelectric Medicine Market in Rest of Europe by Country, 2019-2030, $ mn
Table 28. Spinal Cord Stimulation Device Market by Key Vendor, 2019, %
Table 29. Cochlear Implant Market by Key Vendor, 2019, %
Table 30. Pacemaker and ICD Market by Key Vendor, 2019, %
Table 31. FDA Approved Products of Key Vendors
Table 32. Abbott Laboratories: Company Snapshot
Table 33. Abbott Laboratories: Business Segmentation
Table 34. Abbott Laboratories: Product Portfolio
Table 35. Abbott Laboratories: Revenue, 2018-2020, $ mn
Table 36. BIOTRONIK SE & Co. KG: Company Snapshot
Table 37. Boston Scientific Corp.: Company Snapshot
Table 38. Boston Scientific Corp.: Business Segmentation
Table 39. Boston Scientific Corp.: Product Portfolio of Medical Devices
Table 40. Cochlear Limited: Company Snapshot
Table 41. Cochlear Limited: Operational Overview with Sales Revenue ($ mn) and Sales Volume (units), 2020-2021
Table 42. Cochlear Limited: Product Portfolio
Table 43. electroCore, Inc.: Company Snapshot
Table 44. Inspire Medical Systems, Inc..: Company Snapshot
Table 45. LivaNova PLC: Company Snapshot
Table 46. LivaNova PLC: Product Portfolio
Table 47. Medtronic Inc.: Company Snapshot
Table 48. Medtronic Inc.: Net Revenue by Segment, 2018-2020, $ bn
Table 49. Medtronic Inc.: Net Revenue by Region, 2017-2019, $ bn
Table 50. Medtronic Inc.: Product Portfolio of Medical Devices
Table 51. Medtronic Inc.: Product Portfolio of Bioelectric Medicine
Table 52. NeuroMetrix, Inc: Company Snapshot
Table 53. NeuroMetrix, Inc: Product Portfolio
Table 54. Nevro Corp.: Company Snapshot
Table 55. Nevro Corp.: Product Portfolio
Table 56. Nuvectra Corporation: Company Snapshot
Table 57. Omron Corporation: Company Snapshot
Table 58. Omron Corporation: Business Segmentation
Table 59. Pixium Vision: Company Snapshot
Table 60. Pixium Vision: Product Portfolio
Table 61. Second Sight Medical Products Inc: Company Snapshot
Table 62. Second Sight Medical Products Inc: Product Portfolio
Table 63. SetPoint Medical: Company Snapshot
Table 64. Sonova Holding AG: Company Snapshot
Table 65. Sonova Holding AG: Main Brands and Products
Table 66. St. Jude Medical, Inc.: Company Snapshot
Table 67. Stimwave LLC: Company Snapshot
Table 68. Stimwave LLC: Product Portfolio
Table 69. Risk Evaluation for Investing in Europe Market, 2020-2030
Table 70. Critical Success Factors and Key Takeaways


LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2030
Figure 4. Europe Bioelectric Medicine Market, 2019-2030, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Europe Bioelectric Medicine Market
Figure 7. Worldwide Geriatric Population (60 years and above) by Region, 2015 & 2030, million
Figure 8. World Population 65 and over, % of Total Population, 1950-2060
Figure 9. Primary Restraints and Impact Factors of Europe Bioelectric Medicine Market
Figure 10. Investment Opportunity Analysis
Figure 11. Porter’s Fiver Forces Analysis of Europe Bioelectric Medicine Market
Figure 12. Breakdown of Europe Bioelectric Medicine Market by Product Type, 2020-2030, % of Sales Revenue
Figure 13. Europe Addressable Market Cap in 2021-2030 by Product Type, Value ($ mn) and Share (%)
Figure 14. Europe Bioelectric Medicine Market: Implantable Bioelectric Medicine, 2019-2030, $ mn
Figure 15. Europe Bioelectric Medicine Market: Cardiac Pacemaker, 2019-2030, $ mn
Figure 16. Europe Bioelectric Medicine Market: Implantable Cardioverter Defibrillators (ICD), 2019-2030, $ mn
Figure 17. Europe Bioelectric Medicine Market: Spinal Cord Stimulators, 2019-2030, $ mn
Figure 18. Europe Bioelectric Medicine Market: Cochlear Implants, 2019-2030, $ mn
Figure 19. Europe Bioelectric Medicine Market: Deep Brain Stimulators, 2019-2030, $ mn
Figure 20. Europe Bioelectric Medicine Market: Vagus Nerve Stimulators, 2019-2030, $ mn
Figure 21. Europe Bioelectric Medicine Market: Sacral Nerve Stimulators, 2019-2030, $ mn
Figure 22. Europe Bioelectric Medicine Market: Retinal Implants, 2019-2030, $ mn
Figure 23. Europe Bioelectric Medicine Market: Other Implantable Bioelectric Medicines, 2019-2030, $ mn
Figure 24. Europe Bioelectric Medicine Market: Non-invasive Bioelectric Medicine, 2019-2030, $ mn
Figure 25. Europe Bioelectric Medicine Market: Transcutaneous Electrical Nerve Stimulators, 2019-2030, $ mn
Figure 26. Europe Bioelectric Medicine Market: Transcranial Magnetic Stimulation (TMS), 2019-2030, $ mn
Figure 27. Europe Bioelectric Medicine Market: Pulsed Electromagnetic Field Therapy, 2019-2030, $ mn
Figure 28. Europe Bioelectric Medicine Market: Other Non-invasive Bioelectric Medicines, 2019-2030, $ mn
Figure 29. Breakdown of Europe Bioelectric Medicine Market by End User, 2020-2030, % of Sales Revenue
Figure 30. Europe Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%)
Figure 31. Europe Bioelectric Medicine Market: Hospitals and Clinics, 2019-2030, $ mn
Figure 32. Europe Bioelectric Medicine Market: Research Institutes, 2019-2030, $ mn
Figure 33. Europe Bioelectric Medicine Market: Individual Users, 2019-2030, $ mn
Figure 34. Breakdown of European Bioelectric Medicine Market by Country, 2019 and 2030, % of Revenue
Figure 35. Contribution to Europe 2021-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 36. Bioelectric Medicine Market in Germany, 2019-2030, $ mn
Figure 37. Bioelectric Medicine Market in UK, 2019-2030, $ mn
Figure 38. Bioelectric Medicine Market in France, 2019-2030, $ mn
Figure 39. Bioelectric Medicine Market in Spain, 2019-2030, $ mn
Figure 40. Bioelectric Medicine Market in Italy, 2019-2030, $ mn
Figure 41. Bioelectric Medicine Market in Russia, 2019-2030, $ mn
Figure 42. Bioelectric Medicine Market in Rest of Europe, 2019-2030, $ mn
Figure 43. Growth Stage of Europe Bioelectric Medicine Industry over the Forecast Period


More Publications